Published:
Thursday, July 9, 2009 2:24 PM PDT
San Diego, CA 7/09/2009 Anadys Pharmaceuticals Inc. (ANDS) investors who have been waiting for good news regarding the company's hepatitis C drug program (ANA598) might want to get used to waiting. Given Anadys Pharmaceutical's need for cash before beginning the next phase of testing, and the challenging fund-raising environment, finding a cash-rich development partner may - in retrospect - have been the better and faster solution. Investors and traders are invited to read further analytical review of Anadys...
Published:
Thursday, July 9, 2009 7:58 AM PDT
San Diego, CA Jul 09, 2009 The Small Cap Network (smallcapnetwork.com), a leading online investment community focused on small cap companies, has issued an analysis of Targacept Inc. (TRGT) following the company's announcement on Wednesday regarding its ADHD treatment AZD3480. The NNR Therapeutic (TM) is being developed by Tagacept partner AstraZeneca, which agreed to pay Targecept $10 million for the right to continue developing the deficit/hyperactivity disorder drug. Investors and traders are invited to...
Published:
Thursday, July 9, 2009 7:55 AM PDT
SanDiego, CA Jul 09, 2009 The Small Cap Network (smallcapnetwork.com), a leading online investment community focused on small cap companies, has issued an analysis of Novogen Limited (NVGN) following Tuesday's announcement regarding phenoxodiol. The Malaghan Institute of Medical Research determined that abnormally proliferating human T-cells (rapidly dividing cancer cells) undergo a programmed death when briefly exposed briefly to Novogen's trial tumor drug phenoxodiol. Investors and traders are invited to...
Published:
Thursday, July 9, 2009 7:53 AM PDT
San Diego, CA 7/09/2009 Shares of National Technical Systems Inc. (NTSC) were up sharply on Tuesday and Wednesday, trading on much higher volume than the stock's average. National Technical Systems reached new 52-week lows in May, but have started to make higher highs and higher lows since then. The stock's long-term bottom may have just been hit, according to some technical analysts. Investors and traders are invited to read further analytical review of National Technical Systems Inc. as well as similar opportunities...
Published:
Thursday, July 9, 2009 7:51 AM PDT
San Diego, CA 7/09/2009 The compensation plan for Tandy Brands Accessories Inc. (TBAC) management team as well as the beginning of a new fiscal year may also mark a new trend for Tandy's stock. Shares were sinking and volume was thinning out leading up to the board's meeting. Once the 2010 plan was unveiled, Tandy Brands shares changed their complexion; yesterday's trade for TBAC was the highest in weeks. Investors and traders are invited to read further analytical review of Tandy Brands Accessories Inc. as...
Published:
Wednesday, July 8, 2009 4:57 PM PDT
San Diego, CA Jul 08, 2009 The Small Cap Network (smallcapnetwork.com), a leading online investment community focused on small cap companies, has issued comments regarding yesterday's letter to shareholders from CEL-SCI Corp. (AMEX:CVM) CEO Geert Kersten. The CEO's letter discusses the failure of Tamiflu to effectively treat a handful of swine flu cases, which is a problem that could get worse of the current strain of swine flu swaps genes with the a flu strain commonly called 'bird flu'. If the few cases...
Published:
Wednesday, July 8, 2009 4:52 PM PDT
San Diego, CA 7/08/2009 The wait has been excruciating for Cardiome Pharma Corp. (CRME) investors, not to mention unprofitable. Vernakalant, the company's effective atrial fibrillation treatment is effective to the point of being 'approvable' by FDA standards. However, the FDA's request for more safety information from all vernakalant studies (regardless of the ailment being treated) has dampened investor enthusiasm for shares of Cardiome Pharma. Investors and traders are invited to review a more detailed...
Published:
Wednesday, July 8, 2009 4:51 PM PDT
San Diego, CA 7/08/2009 Shares of Matrixx Initiatives, Inc. (MTXX) have started to tumble again this week in the shadow of June's precipitous move lower. The latest round of selling - minor in comparison to June's dip - was the result of an informal SEC inquiry about potential insider selling. The June selling was triggered by Matrixx Initiatives' failure to properly handle known health risks posed by Zicam. Investors and traders are invited to review a more detailed analytical review of Matrixx Initiatives...
Published:
Wednesday, July 8, 2009 4:49 PM PDT
San Diego, CA 7/08/2009 Shares of BioNeutral Group Inc. (BONU) jumped this morning on news about its antimicrobial agent Ygiene. An independent test performed by AST Labs confirmed that Ygiene was highly effective at eradicating black mold spores. The news and surge in the stock's trading volume appear to have made BONU trade-worthy. Investors and traders are invited to read further analytical review of BioNeutral Group Inc. and a chart as well as similar opportunities by subscribing to the free Small Cap...
Published:
Wednesday, July 8, 2009 9:53 AM PDT
San Diego, CA 7/08/2009 Energy Conversion Devices Inc., despite a broad downturn in the solar power sector, has remained focused and effective in its commercial and rooftop photovoltaic solar cell enterprise. As the Federal Government's stimulus package continues to trickle into the economy, solar power companies like Energy Conversion Devices should start to perform better. Energy Conversion Devices, a manufacturer of a proprietary, thin film laminate announced last month the company had extended a supply...
